The Peptide Lie: What a Drug Developer Reveals About the Compounds Everyone Is Injecting | Dr Leigh Baxt

In this episode of The Proof with Simon Hill, Dr. Leigh Bax, a drug developer with a PhD in microbiology and immunology from Stanford, dismantles the growing mythos around peptides as miracle longevity and wellness therapies. She reveals that most of these compounds are sold under 'for research purposes only' labels, meaning they have not undergone the rigorous FDA-approved drug development process involving preclinical testing, clinical trials, and safety evaluations. Despite this, millions are injecting them based on anecdotal claims and marketing that misrepresents animal and cell study data as human efficacy. Dr. Bax emphasizes that while peptides are not inherently dangerous, the lack of mechanistic understanding, molecular targeting, and human data makes their use a gamble with unknown risks—especially when they stimulate pathways linked to cancer, such as angiogenesis and cell proliferation. She critiques the conflation of regulatory reclassification with scientific validation, warning that moving peptides to a 'compounding' category does not equate to proven safety or effectiveness. Drawing from her decade of experience in early-stage drug development, she underscores the 99% failure rate of drug candidates and the immense complexity of turning a biological idea into a safe, effective medicine. Her message is not anti-peptide, but pro-evidence: people should be informed, cautious, and aware of what they're truly getting when they inject unregulated compounds.